Clinical Feasibility of Multiplex Digital PCR for Major Mutation Detection in NSCLC Patients: The Droplex NSCLC Panel Test

被引：0
|
作者：
Kim, K. A. [1 ]
Ko, J. H. [2 ]
Youn, H. J. [2 ]
Choe, Y-J. [2 ]
Kang, M. R. [2 ]
Shim, H. S. [1 ]
机构：
[1] Yonsei Univ, Seoul, South Korea
[2] Gencurix Inc, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
targetable mutations; Multiplex testing; Digital PCR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.06B.10
引用
收藏
页码：S492 / S493
页数：2
相关论文
共 50 条
  • [41] Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR
    Ntzifa, Aliki
    Kotsakis, Athanasios
    Georgoulias, Vassilis
    Lianidou, Evi
    CANCERS, 2021, 13 (11)
  • [42] Detection of EGFR mutations in plasma cfDNA and paired CTCs of NSCLC patients before and after osimertinib therapy using crystal digital PCR
    Ntzifa, Aliki
    Kotsakis, Athanasios
    Georgoulias, Vassilis
    Lianidou, Evi
    CANCER RESEARCH, 2022, 82 (12)
  • [43] Quantification and Monitoring of Treatment Response in EGFR Mutant NSCLC Patients by Digital-PCR in Plasma cftDNA
    Ludovini, Vienna
    Siggillino, Annamaria
    Reda, Maria Sole
    Bianconi, Fortunato
    Chiari, Rita
    Baglivo, Sara
    Pistola, Lorenza
    Tofanetti, Francesca Romana
    Matocci, Roberta
    Mencaroni, Clelia
    Metro, Giulio
    Bennati, Chiara
    Minotti, Vincenzo
    Crino, Lucio
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1189 - S1190
  • [44] T790M Mutation Detection, Clinical Characteristics and Impact in NSCLC Patients Treated with EGFR Tyrosine Kinase Inhibitors
    Bei, L.
    Oliveira, J.
    Pinheiro, M.
    Veiga, I.
    Peixoto, A.
    Rocha, P.
    Oliveira, C.
    Rodrigues, A.
    Pousa, I.
    Azevedo, I.
    Henrique, R.
    Teixeira, M.
    Soares, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2220 - S2221
  • [45] Comparison of EGFR Mutation Detection in Patients with NSCLC Across Different Platforms: Which Technique Is It Anyway?
    Goqte, P.
    Joshi, P.
    Gurav, M.
    Dhanavade, D.
    Karnik, N.
    Deshpande, G.
    Pai, T.
    Kumar, R.
    Shetty, O.
    Desai, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : S68 - S69
  • [46] Assessment of EGFR mutation status in cf-DNA from patients with NSCLC in a clinical setting
    Michelli, Maria
    Roupou, Eirini
    Giannopoulou, Ioanna
    Prekete, Niki
    Kavantzas, Nikolaos
    Saetta, Angelica A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 908 - 909
  • [47] Clinical Impact of EGFR Mutation on Brain Metastasis in NSCLC Patients: A Meta-Regression Analysis
    Lin, C.
    Yang, S.
    Wu, Y.
    Chang, W.
    Su, P.
    Liao, X.
    Su, W.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1911 - S1911
  • [48] Clinical Management in NSCLC Patients With EGFR Mutation After Osimertinib Progression With Unknown Resistance Mechanisms
    Liao, Xin
    He, Tingting
    Wan, Xiong
    Liu, Pian
    Li, Jing
    He, Yong
    Wang, Yubo
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (10):
  • [49] Phase I clinical pharmacokinetics, safety and tolerability of simotinib in advanced NSCLC patients with EGFR mutation
    Han, X.
    Li, N.
    Hu, X.
    Song, Y.
    Zhang, Y.
    Shi, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S67 - S68
  • [50] Respiratory Viruses Co-detection on a Multiplex RT-PCR Panel: a Comparative Clinical Study
    Choi, Qute
    Kim, Hyun Jin
    CLINICAL LABORATORY, 2024, 70 (07) : 1294 - 1299
12345